RxDoctor Payments Data

Kelly Shuler, DO

Family Medicine · Sapulpa, OKNPI 1376542472

Payments from drug & device makers

$542in general payments, 2019–2025

Across 33 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$338
  • Boehringer Ingelheim$69
  • Novo Nordisk$51
  • Lilly USA, LLC$36
  • Medtronic$26
  • Pfizer$23

What the payments were for

  • Food & beverage$542100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$542 in reported general payments places this provider in the 55th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$88,068
Medicare patients
215
Services billed
5,588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide217$278,227
EliquisApixaban61$57,814
MounjaroTirzepatide32$50,844
TrulicityDulaglutide26$49,787
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$41,712
JanuviaSitagliptin Phosphate22$32,336
JardianceEmpagliflozin14$20,786
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog23$20,042
Breo ElliptaFluticasone/Vilanterol20$14,719
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr26$12,430
VascepaIcosapent Ethyl16$12,319
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$9,786
LinzessLinaclotide12$6,591
Atorvastatin Calcium500$6,323
Omeprazole332$6,168

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$51$278,227217 claims
Lilly USA, LLCMounjaro, Trulicity$36$100,63158 claims
PfizerEliquis$23$57,81461 claims
Boehringer IngelheimJardiance$69$20,78614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Sapulpa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →